Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: J Drug Deliv Sci Technol. 2019 Nov 8;55:101374. doi: 10.1016/j.jddst.2019.101374

Figure 4:

Figure 4:

In-vitro percent cumulative Gem release versus time profiles of free GemHCl and Gem-SLN formulations that entrapped at least 50% of Gem (Gem-SLN4, Gem-SLN10, Gem-SLN11, Gem-SLN13, Gem-SLN15, Gem-SLN16, Gem-SLN17, Gem-SLN20 and Gem-SLN21).